Prohibits the sale or use of prescriber-identifiable prescription data for commercial or marketing purposes without prescriber consent.

Provides that the department of health, in consultation with the appropriate disciplinary boards or commissions, shall establish the prescription drug information integrity program to allow a prescriber to give consent for his or her identifying information to be used for the purposes described under this act.